2-Bromopropionyl chloride | CAS:7148-74-5

We serve 2-Bromopropionyl chloride CAS:7148-74-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Bromopropionyl chloride

Chemical Name:2-Bromopropionyl chloride
CAS.NO:7148-74-5
Synonyms:Propanoyl chloride, 2-bromo-
Molecular Formula:C3H4BrClO
Molecular Weight:171.42000
 
Physical and Chemical Properties:
Density:1.7;
Melting point:-52oC;
Boiling point:131-133oC;
Flash point:125oF;
Index of Refraction:1.477;
 
Specification:
Appearance:Clear,colourless to dark yellow liquid
Purity(GC):≥98.5%
Moisture:≤0.1%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Synthesis:2-Bromopropionyl chloride is prepared by the reaction of (2S)-2-bromopropanoic acid and Thionyl chloride
Application:Applicationd as pharmaceutical intermediates, organic synthesis.



Contact us for information like 2-Bromopropionyl chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Propanoyl chloride, 2-bromo- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Propanoyl chloride, 2-bromo- Use and application,2-Bromopropionyl chloride technical grade,usp/ep/jp grade.


Related News: Australia has started denying entry to all travelers who have come from or transited through mainland China.[(1S,4R)-4-aminocyclopent-2-en-1-yl]methanol,(2S,3S)-2,3-dihydroxybutanedioic acid manufacturer The main API products include antihypertensive, psychotropic and anti-AIDS special APIs. Antihypertensive APIs are mainly pulic and sartan drugs, and they are the world’s major suppliers of pulic and sartan APIs.3-chloro-1,2-benzothiazole 1,1-dioxide supplier The novel coronavirus has resulted in thousands of confirmed human infections in more than 20 countries, with more than 99 percent of cases in China.Trimethyl phosphite vendor The API is not made by only one reaction from the raw materials but rather it becomes an API via several chemical compounds.After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.